> top > docs > PubMed:14691288 > annotations

PubMed:14691288 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 213-228 HP_0012125 denotes prostate cancer
T2 222-228 HP_0002664 denotes cancer
T3 352-358 HP_0002664 denotes tumors
T4 453-463 HP_0000718 denotes aggressive
T5 606-612 HP_0002664 denotes tumors
T6 792-798 HP_0002664 denotes tumors

DisGeNET

Id Subject Object Predicate Lexical cue
T0 119-136 gene:367 denotes androgen receptor
T1 213-228 disease:C0376358 denotes prostate cancer
T2 119-136 gene:367 denotes androgen receptor
T3 213-228 disease:C0600139 denotes prostate cancer
T4 119-136 gene:367 denotes androgen receptor
T5 230-233 disease:C0376358 denotes CaP
T6 119-136 gene:367 denotes androgen receptor
T7 230-233 disease:C0600139 denotes CaP
T8 138-140 gene:367 denotes AR
T9 213-228 disease:C0376358 denotes prostate cancer
T10 138-140 gene:367 denotes AR
T11 213-228 disease:C0600139 denotes prostate cancer
T12 138-140 gene:367 denotes AR
T13 230-233 disease:C0376358 denotes CaP
T14 138-140 gene:367 denotes AR
T15 230-233 disease:C0600139 denotes CaP
R1 T0 T1 associated_with androgen receptor,prostate cancer
R2 T2 T3 associated_with androgen receptor,prostate cancer
R3 T4 T5 associated_with androgen receptor,CaP
R4 T6 T7 associated_with androgen receptor,CaP
R5 T8 T9 associated_with AR,prostate cancer
R6 T10 T11 associated_with AR,prostate cancer
R7 T12 T13 associated_with AR,CaP
R8 T14 T15 associated_with AR,CaP

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
14691288-0#0#17#gene367 83-136 gene367 denotes Androgen action is mediated through androgen receptor
14691288-0#42#57#diseaseC0376358 695-1003 diseaseC0376358 denotes polymorphism and sequencing analyses revealed AR missense mutations in 29% (4/14) of the primary tumors and in one (14%) metastasis. Mutations resided in the transactivation domain and in the hinge region. One of the hinge region mutants, Ser646Phe, that was identified in a patient with short endocrine ther
14691288-0#42#57#diseaseC0600139 695-1003 diseaseC0600139 denotes polymorphism and sequencing analyses revealed AR missense mutations in 29% (4/14) of the primary tumors and in one (14%) metastasis. Mutations resided in the transactivation domain and in the hinge region. One of the hinge region mutants, Ser646Phe, that was identified in a patient with short endocrine ther
14691288-4#77#79#gene367 741-743 gene367 denotes AR
14691288-4#152#162#diseaseC0027627 816-826 diseaseC0027627 denotes metastasis
0#17#gene36742#57#diseaseC0376358 14691288-0#0#17#gene367 14691288-0#42#57#diseaseC0376358 associated_with Androgen action is mediated through androgen receptor,"polymorphism and sequencing analyses revealed AR missense mutations in 29% (4/14) of the primary tumors and in one (14%) metastasis. Mutations resided in the transactivation domain and in the hinge region. One of the hinge region mutants, Ser646Phe, that was identified in a patient with short endocrine ther"
0#17#gene36742#57#diseaseC0600139 14691288-0#0#17#gene367 14691288-0#42#57#diseaseC0600139 associated_with Androgen action is mediated through androgen receptor,"polymorphism and sequencing analyses revealed AR missense mutations in 29% (4/14) of the primary tumors and in one (14%) metastasis. Mutations resided in the transactivation domain and in the hinge region. One of the hinge region mutants, Ser646Phe, that was identified in a patient with short endocrine ther"
77#79#gene367152#162#diseaseC0027627 14691288-4#77#79#gene367 14691288-4#152#162#diseaseC0027627 associated_with AR,metastasis